Game
Bambusa Therapeutics Announces First Subject Dosed in Phase 1 Clinical Trial of BBT001, a Novel Multi-Targeting, Half-Life Extended Bispecific Antibody for the Treatment of Atopic Dermatitis and Other Inflammatory Skin Diseases
Preclinical data with BBT001 demonstrate its best-in-disease potential for improved efficacy and dosing convenience compared to approved biologics in atopic dermatitis
Great Tea Road Retracing: A Journey Along the Ancient Tea Trade Route
WUHAN,China,Feb. 28,2025-- The documentary seriesGreat Tea Road Retracing is produced by Hubei Daily Net. In the series,American tea enthusiast Hannah Carter takes viewers on an exploration along the
Lanvin Group Prioritizes Creative Renewal and Operational Agility Amid Evolving Luxury Landscape
Revenue of €328 million in FY2024,a 23% decrease over FY2023,reflecting a transitional year marked by creative evolution and strategic realignment amid marketheadwinds
Tuya Smart x DeepSeek: The Revolutionary Path Empowered by Emotional Home Robots
NEW YORK,Feb. 28,2025-- Tuya Smart (NYSE: TUYA,HKEX: 2391),a global AI cloud platform service provider,has integrated the DeepSeek large language model into its AIoT platform,helping global developers
Aduna and Bridge Alliance partner to accelerate access to network APIs
STOCKHOLM,March 2,2025-- Aduna,a landmark venture between some of the world\'s leading telecom operators and Ericsson,is set to partner with Bridge Alliance to accelerate the adoption of CAMARA-based
DXC Names Former COO at Federal Reserve, Pat McClanahan, as Global Leader of Business and Sales Operations for Consulting & Engineering Services
ASHBURN,Va.,Feb. 27,2025-- DXC Technology (NYSE: DXC),a leading Fortune 500 global technology services provider,today announced the appointment of Pat McClanahan as Global Leader of Business and Sale
First Patient Dosed in a Phase III Clinical Study of Anti-HER2 Biparatopic ADC JSKN003 for the Treatment of HER2-positive Breast Cancer
SUZHOU,China,Feb. 27,2025-- Alphamab Oncology (Stock Code: 9966.HK) and CSPC Pharmaceutical Group Co.,Ltd. ("CSPC") (Stock Code: 1093.HK) jointly announced that the first patient has been su
Minesto publishes Year-End Report 2024
GOTHENBURG,Sweden,Feb. 27,2025-- CEO Dr. Martin Edlund: "Minesto has now demonstrated competitive renewable energy production from an untapped natural resource based on a truly novel and propriet
Metabolon Unveils New Multiomics Biomarker Discovery Functionality via its Industry-leading Integrated Bioinformatics Platform
Metabolon\'s expertise extends beyond metabolomics to include data insights and software solutions for multiomics research
Silverfort Stakes Its Claim in Identity Security with Patented Architecture and Rebrand, as Demand for the Market Accelerates
Introducing Runtime Access Protection (RAP) enabling the first end-to-end identity security platform,securing every identity across hybrid environments and disrupting siloed categories like NHI,PAM,M